--- title: "Kanzhun Details March–May 2026 Share Buybacks and Stable Share Capital" type: "News" locale: "en" url: "https://longbridge.com/en/news/286255861.md" description: "Kanzhun Ltd reported stable share capital of 840,422,467 Class A shares on the Hong Kong Stock Exchange as of May 12, 2026. The company conducted on-market repurchases of Class A shares from March 20 to May 12, 2026, totaling 704,636 shares for cancellation, aimed at reducing free-float shares and enhancing earnings per share. All transactions complied with Hong Kong listing rules. Analysts rate BZ stock as a Buy with a $19.00 price target, reflecting strong financial performance despite neutral technical momentum." datetime: "2026-05-13T11:46:10.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286255861.md) - [en](https://longbridge.com/en/news/286255861.md) - [zh-HK](https://longbridge.com/zh-HK/news/286255861.md) --- # Kanzhun Details March–May 2026 Share Buybacks and Stable Share Capital ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Kanzhun Ltd Sponsored ( (BZ) ) just unveiled an update. Kanzhun Limited reported to the U.S. Securities and Exchange Commission in a Form 6-K for May 2026 that its issued share capital on the Hong Kong Stock Exchange remained unchanged at 840,422,467 Class A ordinary shares between May 11 and May 12, 2026, with no treasury shares outstanding. As disclosed in a Next Day Disclosure Return dated May 13, 2026, the company detailed a series of on-market repurchases of Class A shares from March 20 through May 12, 2026 for cancellation, signaling continued capital management while confirming that 704,636 Class A shares remained on deposit to support future ADS issuances under its share incentive plans as of May 12, 2026. These repurchases at prices generally between about US$6.58 and US$7.25 per share reflect Kanzhun’s ongoing effort to reduce free-float shares and potentially enhance earnings per share, without immediately altering the reported issued share count by the May 12, 2026 balance date. The filing’s confirmations indicate that all buybacks and related share arrangements complied with Hong Kong listing rules and applicable legal requirements, offering assurance to shareholders and regulators about the integrity of Kanzhun’s equity transactions and its disciplined approach to balance-sheet optimization. The most recent analyst rating on (BZ) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Kanzhun Ltd Sponsored stock, see the BZ Stock Forecast page. **Spark’s Take on BZ Stock** According to Spark, TipRanks’ AI Analyst, BZ is a Outperform. The score is driven primarily by strong financial performance (profitability, cash flow strength, and low leverage) and a constructive earnings-call outlook with meaningful shareholder returns. These positives are tempered by weak-to-neutral technical momentum and a valuation that appears fair rather than clearly cheap. To see Spark’s full report on BZ stock, click here. **More about Kanzhun Ltd Sponsored** Kanzhun Limited, incorporated in the Cayman Islands and headquartered in Beijing, is a foreign private issuer listed in Hong Kong with weighted voting rights ordinary shares. The company’s equity structure centers on Class A ordinary shares, some of which back American depositary shares reserved for future issuance under its share incentive plans. **Average Trading Volume:** 4,076,107 **Technical Sentiment Signal:** Sell **Current Market Cap:** $6.96B ### Related Stocks - [BZ.US](https://longbridge.com/en/quote/BZ.US.md) - [02076.HK](https://longbridge.com/en/quote/02076.HK.md) ## Related News & Research - [BOSS Zhipin's Ongoing Share Repurchases Cross the RMB1 Billion Mark in 2026 | BZ Stock News](https://longbridge.com/en/news/283982781.md) - [Kanzhun Details March–April 2026 Buybacks With No Change in Total Issued Shares](https://longbridge.com/en/news/284011713.md) - [ONWARD Medical to Announce First Quarter 2026 Results on May 26, 2026 | ONWRY Stock News](https://longbridge.com/en/news/286858298.md) - [Transactions in connection with share buy-back program](https://longbridge.com/en/news/286746558.md) - [Hims CFO Oluyemi Okupe sells 7,950 shares for $187,914.74](https://longbridge.com/en/news/286977239.md)